Browsing by Author "Scheu Goncalves, Christian Andrés"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Clinical profile of children with diabetic ketoacidosis in fifteen years of management in a Critical Care Unit
    (2018) Del Pozo Bascuñan, Paulina Andrea; Aránguiz, Diego; Córdova Lazo, Guiliana; Scheu Goncalves, Christian Andrés; Valle Múñoz, Patricio Alejandro; Cerda, Jaime; García Bruce, Hernán; Hodgson Bunster, María Isabel; Castillo Moya, Andres Eduardo
  • Thumbnail Image
    Item
    Experiencia en COVID-19 en pacientes hospitalizados en unidades de paciente crítico pediátrico durante el periodo pandémico
    (Sociedad Chilena de Perdiatría, 2023) Wegner Araya, Adriana; Céspedes Fernández, Pamela; Astudillo Paredes, Patricio; Diettes González, Adriana; Díaz Rubio, Franco; Scheu Goncalves, Christian Andrés; Chauriye Kuncar, Verónica; Gaete Amenábar, Tomás; Zamora Astudillo, Marta; Acuña Aguirre, Carlos; Drago Thibaut, Michele; Monreal Eloaiza, Víctor; Lapadula Amelina, Michelangelo; Pietroboni Fuster, Pietro; Varela Ortiz, Javier; Gallardo Martínez, Alena; Scheuch Ruiz, Karin; Manen Chinchón, Andrés; Villarroel Carreño, María José; Verscheure Peralta, Felipe; Maldonado Valenzuela, Blanca; Meyer Flores, Matías
    Objetivo: Caracterizar el comportamiento de COVID-19 en niños chilenos hospitalizados en unidades de paciente crítico pediátrico (UPCP) y evaluar factores de riesgo para COVID-19 severo. Pacientes y Método: Estudio multicéntrico cohorte prospectivo, pacientes 0-18 años con SARS-CoV-2 confirmado hospitalizados en UPCP. Se registraron variables clínicas, laboratorio, imagenológicas y terapéuticas. Se comparó “COVID-19 leve/moderado” versus “COVID-19 severo” utilizando mediana con rango intercuartil (RIC), test U Mann-Whitney, Test Fisher de dos colas y análisis multivariado binario forward para ajuste de variables para “COVID-19 severo”. Significativo p < 0,05. Resultados: 219 pacientes, 55,3% hombres, mediana edad 86 meses (RIC: 13,5-156). Comorbilidades principales: obesidad, enfermedades respiratorias. Mortalidad global: 3,6%. “COVID-19 severo” (26,5%) mostró más leucopenia, linfopenia, más inflamación y alteración de órganos (p < 0,05). También desarrolló más Sepsis/shock, SDRA y disfunción de órganos, requirió más terapia hemodinámica, antiinflamatoria, anticoagulación, antibioterapia, con mayor estadía en UPCP/hospitalaria (p < 0,05) y mortalidad de 13,8%. Factores de riesgo asociados a “COVID-19 severo”: shock al ingreso (aOR 28,44 [IC95%: 10,45-77,4]), obesidad (aOR 3,55 [IC95%: 1,3-9,6]), condensación (aOR 3,1 [IC95%: 1,1-8,7]), atelectasia (aOR: 8.7 [IC95%: 1,17-64,3]), corticoides dosis de estrés (aOR 7,7 [IC95%: 1,9-30,6]), antibioterapia precoz (aOR: 12,02 [IC95%: 1,11-130,02]), inmunodeficiencia adquirida/ congénita (aOR: 19,2 [IC95%: 1,19-321]) y patología oncológica (aOR: 10,7 [IC95%: 2,14-47,8]). Conclusión: En esta cohorte pediátrica chilena, el perfil de paciente que ingresó a UPCP fue de sexo masculino en edad escolar con comorbilidad asociada. Factores de riesgo asociados a COVID-19 severo fueron: presencia de comorbilidades (inmunodeficiencia adquirida/congénita, patología oncológica y obesidad), shock al ingreso y condensaciones en las imágenes radiológicas.
  • Thumbnail Image
    Item
    Guía de recomendaciones para el manejo de pacientes pediátricos con enfermedad severa por SARS-COV-2
    (2020) Scheu Goncalves, Christian Andrés; Diettes González, A.; Wegner Araya, A.; Bravo Figueroa, P.; Drago Thibaut, M.; Nalegach Romero, M. E.; Castillo Moya, Andres Eduardo; Verscheure Peralta, F.; Acuña Aguirre, C.; Díaz Rubio, F.; Ortiz, P.; Cordero, J.; Dalmazzo Álvarez, R.; Valverde Goñi, C.; Yunge Bertini, M.
  • Thumbnail Image
    Item
    Latin American Consensus for Pediatric Cardiopulmonary Resuscitation 2017 : Latin American Pediatric Critical Care Society Pediatric Cardiopulmonary Resuscitation Committee*
    (2018) Lopez-Herce, J.; Almonte, E.; Alvarado, M.; Bogado, N.B.; Cyunel, M.; Escalante Rivas, María José; Finardi, C.; Guzman, G.; Jaramillo-Bustamante, J.C.; Scheu Goncalves, Christian Andrés; Madrid, C.C.; Matamoros, M.; Moya, L.A.; Obando, G.; Reboredo, G.; Lopez, L.R.; Valenzuela, A.; Yerovi, R.; Yock-Corrales, A.
  • No Thumbnail Available
    Item
    Surgical Site Infection in Pediatric Patients Undergoing Cardiac Surgery with Delayed Sternal Closure: Experience from a Center in Chile (2015–2020)
    (2025) Jiménez Paredes, Daniela; Valderrama E., Paulo; Correa Irarrázaval, Nicolas; Cerda Lorca, Jaime Rodrigo; Riquelme Parada, Maria Ines; Becker Rencoret, Pedro Antonio German; Gonzalez Foretic, Rodrigo Vicente; Scheu Goncalves, Christian Andrés; Claveria Rodríguez, Cristian
    Delayed sternal closure (DSC) is a technique used in complex cardiac surgery (CCS) and is associated with an increased risk of surgical site infection (SSI). SSI increases hospital stay and healthcare costs, with an incidence ranging from 1.5% to 34%. To determine the SSI rate and associated risk factors in patients with congenital heart disease (CHD) undergoing CCS with DSC between January 2015 and December 2020, and to compare them with previous results, before the implementation of measures by the Healthcare-Associated Infections Committee (HAIC). A descriptive study was conducted inpatients under 18 years of age who required DSC between 2015 and 2020 at the Hospital of Pontifical Catholic University of Chile, meeting the Chilean Ministry of Health’s definition of SSI. SSI rates were compared between the periods 2009–2010 and 2015–2020 using the Poisson rate ratio. A total of 1,471 surgeries were performed, of which 138 (9.38%) required DSC and 6 (4.34%) presented SSI. 67% were males older than 7 days, with one patient premature. 66.7% had extracorporeal circulation (ECC)>200 min and 83.3% required mechanical ventilation (MV)>5 days. Several SSI-causingmicroorganisms were identified. Comparing both studies, a decrease in the prevalence of SSI in DSC was found from 22% to 4.3%, with a rate ratio of 5.16 (95% IC 1.83–16.54, p=0.001), with no significant differences in the risk factors identified in the initial study (ECC>200 min and MV>5 days). The SSI rate was 4.34%, a significant decrease compared to the previous study, attributed to improvements in cardiovascular management and IAAS Committee measures.